Back to Search
Start Over
Study of potent CDK7 inhibitor secondary metabolites from Tecomella undulata .
- Source :
-
Natural product research [Nat Prod Res] 2022 Nov; Vol. 36 (22), pp. 5793-5797. Date of Electronic Publication: 2022 Jan 04. - Publication Year :
- 2022
-
Abstract
- Chemical investigation of the petroleum ether extract of heartwood of Tecomella undulata led to the isolation of tectonaquinone B (1), 2-methylquinizarin (2) along with tecomaquinone I (3), lapachol (4), 2-isopropenylnaphtho[2,3-b]-furan-4,9-quinone (5), dehydro-α-lapachone (6), α-lapachone (7), and β-lapachone (8). This is the first report of isolation of tectonaquinone B and 2-methylquinizarin from this plant. The structures of compounds were elucidated by advanced spectroscopic methods. Molecular docking study for potential inhibitory action toward CDK7 (cyclin-dependent kinase 7) were performed, which proved that these compounds have high binding affinities with the receptor protein (CDK7). 2-Methylquinizarin exhibited best docking score (-7.70 kcal/mol) among all the tested compounds. The present study showed that 2-methylquinizarin may exhibit potent anticancer activity through inhibiting CDK7 via interaction with Met94.
- Subjects :
- Molecular Docking Simulation
Plant Extracts pharmacology
Bignoniaceae chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1478-6427
- Volume :
- 36
- Issue :
- 22
- Database :
- MEDLINE
- Journal :
- Natural product research
- Publication Type :
- Academic Journal
- Accession number :
- 36411529
- Full Text :
- https://doi.org/10.1080/14786419.2021.2016748